Last $23.84 USD
Change Today -0.49 / -2.01%
Volume 9.3M
HOLX On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 10/1/14 All times are local (Market data is delayed by at least 15 minutes).

hologic inc (HOLX) Snapshot

Open
$24.35
Previous Close
$24.33
Day High
$24.36
Day Low
$23.15
52 Week High
07/31/14 - $26.75
52 Week Low
11/12/13 - $19.25
Market Cap
6.6B
Average Volume 10 Days
3.5M
EPS TTM
$-1.13
Shares Outstanding
277.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HOLOGIC INC (HOLX)

hologic inc (HOLX) Related Businessweek News

No Related Businessweek News Found

hologic inc (HOLX) Details

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women. The company’s Breast Health segment offers full field digital mammography, C-view, screen-film mammography, computer aided detection, Trident specimen radiography, and stereotactic breast biopsy systems; healthcome mammography, breast biopsy, and breast brachytherapy products; and breast tomosynthesis, Selenia full field digital mammography platform, SecurView workstation, MammoPad breast cushions, photoconductor coatings, and Sentinelle medical magnetic resonance imaging breast coils and workstations. Its Diagnostics segment provides APTIMA family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assays, instrumentation, Invader chemistry platform, Cervista HPV tests, ThinPrep system, fetal fibronectin tests, Procleix family of assays, and infectious disease and virology products. The company’s GYN Surgical segment offers NovaSure system to treat women suffering from abnormal uterine bleeding; MyoSure system for the hysteroscopic removal of fibroids; and Aquilex Fluid Control System to measure the inflow and outflow of fluid from the patient during hysteroscopic procedures. Its Skeletal Health segment provides discovery and horizon X-ray bone densitometers that assess the bone density of fracture sites; Sahara clinical bone sonometers, which assess the bone density of heels; and mini C-arm imaging systems to perform minimally invasive surgical procedures on a patient’s extremities. Hologic, Inc. sells its products through direct sales and service forces, and a network of independent distributors and sales representatives primarily in the United States, Europe, and the Asia-Pacific. The company has a strategic alliance with Quest Diagnostics Incorporated. Hologic, Inc. was founded in 1985 and is headquartered in Bedford, Massachusetts.

5,615 Employees
Last Reported Date: 11/26/13
Founded in 1985

hologic inc (HOLX) Top Compensated Officers

Chief Administrative Officer, Senior Vice Pre...
Total Annual Compensation: $425.0K
Senior Vice President of Corporate Strategy
Total Annual Compensation: $399.7K
Executive Officer
Total Annual Compensation: $599.5K
Executive Officer
Total Annual Compensation: $349.1K
Compensation as of Fiscal Year 2013.

hologic inc (HOLX) Key Developments

Mevis Medical Solutions AG Enters into a Collaborative Software Development Agreement with Hologic, Inc

MeVis Medical Solutions AG announced that it has entered into a collaborative software development agreement with its Hologic Inc. The agreement relates to the development of software applications for certain of Hologic's mammography products. This is the second contract between MeVis and Hologic in 2014. Earlier this year MeVis announced that the parties had agreed to extend the previous software licensing agreement through the end of 2015 with amended terms. The current licensing and maintenance business with Hologic is expected to gradually be converted to one of development support.

Hologic Inc. Announces Resignation of Rohan F. Hastie as Executive Officer

On September 2, 2014, Rohan F. Hastie announced his resignation as an executive officer of Hologic Inc. Prior to his resignation, Mr. Hastie served as Division President, Diagnostics. Mr. Hastie will remain with the company until November 28, 2014, the effective date of his resignation, to assist in the transition to a new Division President, Diagnostics.

Hologic's Horizon DXA Platform for Osteoporosis, Cardiovascular Disease, and Obesity Assessment Receives Regulatory Approval in Canada

Hologic Inc. announced that Health Canada granted a medical device license for Horizon, a new DXA (dual-energy x-ray absorptiometry) imaging platform that assists in the assessment of three critical health problems - osteoporosis, cardiovascular disease, and obesity. The Horizon DXA platform is designed to offer improved precision, stability and throughput over current products. New, clinically relevant built-in enhancements include a high-resolution multi-element detector array with ceramic detector technology for improved bone mapping and image quality; a high-frequency pulsing power supply that offers greater system stability and future flexibility; and a filter drum to support future development initiatives. Built on Hologic proprietary technologies, Horizon offers expanded technical capabilities, workflow efficiencies and improved design components to meet clinician needs now and into the future. The Hologic Horizon DXA platform offers the following features: A Single Energy Femur Exam designed to allow clinicians to visualize potential atypical femur fractures, an unusual form of femur fracture which can occur as the result of bisphosphonate use. High Definition Instant Vertebral Assessment (IVA-HD) capability for significantly improved detection of vertebral fractures. An Abdominal Aortic Calcification feature through Hologic's IVA-HD technology designed to enable clinicians to visualize abdominal aortic calcifications, a significant predictor of cardiovascular disease. Advanced Body Composition assessment with visceral fat estimation to assist in the evaluation of metabolic health.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HOLX:US $23.84 USD -0.49

HOLX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
DENTSPLY International Inc $45.31 USD -0.29
MEDNAX Inc $53.69 USD -1.13
Mettler-Toledo International Inc $251.79 USD -4.34
PerkinElmer Inc $42.85 USD -0.75
ResMed Inc $49.50 USD +0.23
View Industry Companies
 

Industry Analysis

HOLX

Industry Average

Valuation HOLX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.7x
Price/Book 3.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HOLOGIC INC, please visit www.hologic.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.